EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Budding Unveiled: Clinicopathological Correlations and Survival Insights From a Tertiary Care Cancer Center of India

Ipsita Dhal iD, Himani Rai iD, Neha Singh iD, Ahmad Raza iD, Divya Khichi, Isha Makker iD, Zachariah Chowdhury, Shashikant Patne iD, Parul Tripathi, Ankita Pal iD, Anuj Gupta iD, Mayank Tripathi iD und 1 weitere

International Journal of Breast Cancer · 2026-01 · 2026 (1)

DOI: 10.1155/ijbc/6846485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Breast Cancer, online erschienen am 24.08.2026. Verfasst von Ipsita Dhal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncopathology, Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor budding (TB), defined as isolated single cells or small clusters at the invasive front, has emerged as a potential adverse prognostic marker in breast cancer (BC), though its clinical utility remains uncertain.

Methods

This retrospective study included 229 cases of invasive breast carcinoma. TB was assessed on hematoxylin and eosin (H&E) sections, with AE1/AE3 immunostaining in equivocal cases. TB was analyzed both as a continuous and categorical variable for its association with clinicopathological parameters, including lymph node metastasis, lymphovascular invasion (LVI), distant metastasis, tumor size, nodal stage, age, and hormone receptor status. Patients were followed for 5.75 years to evaluate progression‐free survival (PFS) and overall survival (OS).

Results

High tumor budding (HTB) was identified in a significant proportion of cases and showed strong correlation with adverse clinicopathological features, including lymph node positivity, LVI, higher nodal stage, and distant metastasis. HTB was more frequent in hormone receptor–positive tumors and less common in triple‐negative BC. No significant association was observed between TB and PFS or OS during follow‐up.

Conclusion

TB is a cost‐effective histopathological marker associated with adverse clinicopathological features in BC. Although no significant association with survival outcomes was observed in the present cohort, its correlation with established adverse pathological parameters highlights its potential clinical relevance. Larger prospective studies with standardized assessment criteria are needed to further clarify its prognostic significance and clinical utility.

Autor:innen und Institutionen

  • Department of Oncopathology, Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.
  • Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India, bhu.ac.in.
  • Department of Pathology, Artemis Hospital, Gurgaon, New Delhi, India, artemishospitals.com.
  • Department of Clinical Research Secretariat, Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.
  • Department of Medical Oncology, Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.
  • Department of Surgical Oncology, Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Homi Bhabha National Institute, Varanasi, India, hbni.ac.in.

ORCID-Profile: Ipsita Dhal, Himani Rai, Neha Singh, Ahmad Raza, Isha Makker, Shashikant Patne, Ankita Pal, Anuj Gupta, Mayank Tripathi

Zitieren

APA

Dhal, I., Rai, H., Singh, N., Raza, A., Khichi, D., Makker, I., Chowdhury, Z., Patne, S., Tripathi, P., Pal, A., Gupta, A., Tripathi, M., & Mishra, B. K. (2026). Tumor Budding Unveiled: Clinicopathological Correlations and Survival Insights From a Tertiary Care Cancer Center of India. International Journal of Breast Cancer, 2026(1). https://doi.org/10.1155/ijbc/6846485

Vancouver

Dhal I, Rai H, Singh N, Raza A, Khichi D, Makker I, et al. Tumor Budding Unveiled: Clinicopathological Correlations and Survival Insights From a Tertiary Care Cancer Center of India. International Journal of Breast Cancer. 2026;2026(1). doi:10.1155/ijbc/6846485

BibTeX
@article{Dhal2026,
  author = {Dhal, Ipsita and Rai, Himani and Singh, Neha and Raza, Ahmad and Khichi, Divya and Makker, Isha and Chowdhury, Zachariah and Patne, Shashikant and Tripathi, Parul and Pal, Ankita and Gupta, Anuj and Tripathi, Mayank and Mishra, Bal Krishna},
  title = {Tumor Budding Unveiled: Clinicopathological Correlations and Survival Insights From a Tertiary Care Cancer Center of India},
  journal = {International Journal of Breast Cancer},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijbc/6846485}
}
Kostenlos starten →